CA
PAHC icon

Continuum Advisory’s Phibro Animal Health PAHC Stock Holding History

Continuum Advisory’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-66
Closed -$1.41K – 1218
2025
Q1 		$1.41K Buy
66
+14
+27% +$313 ﹤0.01% 1444
2024
Q4 		$1.09K Hold
52
– – ﹤0.01% 1597
2024
Q3 		$1.29K Buy
+52
New +$1K ﹤0.01% 1575

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Continuum Advisory's PAHC Position: Q2 2025 in Review

Continuum Advisory sold out of Phibro Animal Health (PAHC) in Q2 2025, closing a stake of 66 shares — an estimated $1.41K sold.

Continuum Advisory first reported a position in PAHC in Q3 2024 and held it in 3 quarters. The position peaked at $1.41K in Q1 2025. 194 funds tracked by Wall St. Rank hold PAHC as of Q2 2025.

  • Continuum Advisory reported no remaining Phibro Animal Health position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 66 Phibro Animal Health shares in Q2 2025, an estimated $1.41K.
  • Continuum Advisory first reported a position in Phibro Animal Health in Q3 2024 and held it in 3 quarters.
  • Continuum Advisory's Phibro Animal Health position peaked at $1.41K in Q1 2025.
  • 194 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.